Review Article
Cryptococcosis in Hematopoietic Stem Cell Transplant Recipients: A Rare Presentation Warranting Recognition
Table 2
Demographic and clinical characteristics of hematopoietic stem cell transplant recipients with cryptococcosis and characteristics of the disease.
| Characteristic | Number (%) |
| Gender (n = 17) | Male | 9 (52.9) | Female | 8 (47.1) | Primary hematologic disease (n = 16) | Multiple myeloma | 4 (25.0) | Acute myelogenous leukemia | 3 (18.8) | Acute lymphoblastic leukemia | 2 (12.5) | Peripheral T-cell lymphoma | 2 (12.5) | Diffuse large B-cell lymphoma | 1 (6.3) | Follicular lymphoma | 1 (6.3) | Hodgkin’s lymphoma | 1 (6.3) | Myelodysplastic syndrome | 1 (6.3) | Unspecified leukemia | 1 (6.3) | Transplant type (n = 22) | Allogeneic | 11 (50.0) | Autologous | 11 (50.0) | Site of infection (n = 23) | CNS | 12 (52.2) | Cryptococcemia | 4 (17.4) | Disseminated | 3 (13.0) | Pulmonary | 2 (8.7) | Other | 2 (8.7) | Outcome (n = 20) | Dead | 10 (50.0) | Alive | 10 (50.0) | Species (n = 21) | Cryptococcus neoformans | 13 (61.9) | Cryptococcus laurentii | 3 (14.3) | Cryptococcus sp. | 2 (9.5) | Cryptococcus adeliensis | 1 (4.8) | Cryptococcus albidus | 1 (4.8) | Cryptococcus terreus | 1 (4.8) | | Median (range) | Age (years) (n = 17) | 47 (12–74) | Time of onset after HSCT (days) (n = 20) | 57.5 (0–1825) |
|
|
n, number of cases with available data from the patients.
|